Key Metrics
CiteScore 

5.8
Eigenfactor 

0.005 - 0.01
Impact Factor 

< 5
SJR 

Q2Biochemistry

SNIP 

1.02
Recommended pre-submission checks
Powered by 

Topics Covered on Metabolic Brain Disease
Metabolic Brain Disease Journal Specifications
| Overview | |
| Publisher | SPRINGER/PLENUM PUBLISHERS |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 1986 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Metabolic Brain Disease ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Metabolic Brain Disease
Genistein-3'-sodium sulfonate improves neuroinflammation, blood-brain barrier function, and microglial activation after chronic cerebral hypoperfusion by regulating TGR5.
- 20 May 2026
- Metabolic brain disease
Neuroprotective effects of myrtenol against brain injury following isoproterenol-induced myocardial infarction in male rats.
- 20 May 2026
- Metabolic brain disease
Mild hypothermia inhibits the inflammatory response and microglial M1 polarization in ischemic stroke via the EFNB2/EphB4 pathway.
- 20 May 2026
- Metabolic brain disease
Neuroprotective effects of trans-anethole on AlCl₃-induced memory impairment: targeting AChE, oxidative stress, and NLRP3 inflammasome: a promising approach for neurodegeneration prevention.
- 19 May 2026
- Metabolic brain disease
Impact of prenatal LPS on sepsis-related neurobiological outcomes.
- 19 May 2026
- Metabolic brain disease
Plant-derived neuroprotective compounds and nanoformulations targeting Parkinson's disease: a semi-systematic review of mechanisms and therapeutic potential.
- 19 May 2026
- Metabolic brain disease
Genistein-3'-sodium sulfonate improves neuroinflammation, blood-brain barrier function, and microglial activation after chronic cerebral hypoperfusion by regulating TGR5.
- 20 May 2026
- Metabolic brain disease
Neuroprotective effects of myrtenol against brain injury following isoproterenol-induced myocardial infarction in male rats.
- 20 May 2026
- Metabolic brain disease
Mild hypothermia inhibits the inflammatory response and microglial M1 polarization in ischemic stroke via the EFNB2/EphB4 pathway.
- 20 May 2026
- Metabolic brain disease
Neuroprotective effects of trans-anethole on AlCl₃-induced memory impairment: targeting AChE, oxidative stress, and NLRP3 inflammasome: a promising approach for neurodegeneration prevention.
- 19 May 2026
- Metabolic brain disease
Impact of prenatal LPS on sepsis-related neurobiological outcomes.
- 19 May 2026
- Metabolic brain disease
Plant-derived neuroprotective compounds and nanoformulations targeting Parkinson's disease: a semi-systematic review of mechanisms and therapeutic potential.
- 19 May 2026
- Metabolic brain disease
FAQs on Metabolic Brain Disease
How long has Metabolic Brain Disease been actively publishing? 
What is the publishing frequency of Metabolic Brain Disease? 
How many articles did Metabolic Brain Disease publish last year? 
What is the eISSN & pISSN for Metabolic Brain Disease? 
What is Citescore for Metabolic Brain Disease? 
What is SNIP score for Metabolic Brain Disease? 
What is the SJR for Metabolic Brain Disease? 
Who is the publisher of Metabolic Brain Disease? 
Check if your manuscript is a good match for
undefined
Upload your manuscript to get recommendations of journals
that have published papers similar to your manuscript
Drag and drop your file here
We accept manuscripts in English. File format: .doc and .docx | Maximum size: 10 MB | Word count: 200-300,000 words | File length: less than 100 pages
Do not have a manuscript right now? Use an abstract or summary